Puigoriol-Illamola D, Martínez-Damas M, Griñán-Ferré C, Pallàs M. Int J Mol Sci. 2020 Feb 10;21(3):1154. doi: 10.3390/ijms21031154.

Disease-modifying treatment with I 2 imidazoline receptor ligand LSL60101 in an Alzheimer’s disease mouse model: a comparative study with donepezil
Vasilopoulou F, Rodríguez-Arévalo S, Bagán A, Escolano C, Griñán-Ferré C, Pallàs M. Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in…